Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
72
-
Total shares
-
29.1M
-
Shares change
-
+12.1M
-
Total reported value, excl. options
-
$639M
-
Value change
-
+$267M
-
Number of buys
-
65
-
Number of sells
-
-10
-
Price
-
$22.00
Significant Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q2 2018
71 filings reported holding APLS - Apellis Pharmaceuticals, Inc. - Common Stock as of Q2 2018.
Apellis Pharmaceuticals, Inc. - Common Stock (APLS) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.1M shares
of 124M outstanding shares and own 23.36% of the company stock.
Largest 10 shareholders include Hillhouse Capital Management, Ltd. (4.33M shares), Cormorant Asset Management, LP (4.31M shares), BlackRock Inc. (2.8M shares), Sectoral Asset Management Inc (1.74M shares), Vivo Capital, LLC (1.46M shares), FMR LLC (1.34M shares), VANGUARD GROUP INC (1.34M shares), STATE STREET CORP (1.21M shares), PRICE T ROWE ASSOCIATES INC /MD/ (962K shares), and VICTORY CAPITAL MANAGEMENT INC (933K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.